Showing 1671-1680 of 3763 results for "".
Treatment Guidelines for the PicoWay® Laser System in Skin of Color
https://practicaldermatology.com/topics/general-topics/treatment-guidelines-for-the-picoway-laser-system-in-skin-of-color/22087/Picosecond laser therapy for benign pigmented lesionsThe Future of Treatment and Research for Giant Congenital Melanocytic Nevi
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-future-of-treatment-and-research-for-giant-congenital-melanocytic-nevi/57252/Congenital melanocytic nevi (CMN) have long posed a clinical paradox: lesions that are often benign in behavior yet burdened by a measurable risk of melanoma and significant psychosocial impact. Present at birth or emerging in early infancy, CMN vary widely in size, distribution, and long-term impliMaui Derm 2024 and Maui Derm Caribbean: Top Stories, Interviews, and More
https://practicaldermatology.com/conferences/maui-derm-2024/maui-derm-2024-and-maui-derm-caribbean-top-stories-interviews-and-more/24043/The sun was bright, and the science was hot at Maui Derm 2024, held at the Grand Wailea Resort in Maui, Hawaii. From new therapies to innovative techniques to treatments in the pipeline, presenters and attendees were eager to share updates and findings at this popular annual event.Comorbidities in Psoriasis
https://practicaldermatology.com/topics/psoriasis/comorbidities-in-psoriasis/54453/Psoriasis is associated with numerous systemic comorbidities, many of which are linked through IL-17/IL-23-mediated inflammation. Comorbid conditions such as diabetes, IBD, metabolic syndrome, and PsA are not only more prevalent but often more severe in psoriasis patients, highlighting the importanAI and Skin of Color: Hidden Biases Raise Questions
https://practicaldermatology.com/topics/skin-of-color/ai-and-skin-of-color-hidden-biases-raise-questions/23994/AI holds potential for practitioners, but it’s important to think critically about what data we use to build models.D as in Delta: The Changing Views on Vitamin D in Dermatology
https://practicaldermatology.com/topics/atopic-dermatitis/d-as-in-delta-the-changing-views-on-vitamin-d-in-dermatology/23616/Evidence suggests that vitamin D supplementation may benefit some patients with AD.Advanced Management Solutions for High-Grade Cutaneous Toxicities to Cancer Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advanced-management-solutions-for-high-grade-cutaneous-toxicities-to-cancer-therapy/57176/The emergence of immune checkpoint inhibitors (ICIs) has fundamentally altered the prognosis for patients with advanced skin malignancies, yet the high incidence of cutaneous immune-related adverse events (irAEs) remains a significant barrier to treatment continuity. Here, we review the clinical manCase Report: Treatment of Refractory Pemphigus Foliaceus with Rituximab; Financial Matters; AAD; ASDS Resources
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-treatment-of-refractory-pemphigus-foliaceus-with-rituximab-financial-matters-aad-asds-resources/21033/A Novel Topical Cream to Reduce Bruising
https://practicaldermatology.com/topics/general-topics/a-novel-topical-cream-to-reduce-bruising/21476/Although options to treat bruising have been limited, a new cream may be especially useful for older patients.Multi-Faceted approaches to rosacea Management
https://practicaldermatology.com/topics/general-topics/multi-faceted-approaches-to-rosacea-management/22919/Patients are increasingly using cosmeceuticals—with and without prescription agents— to manage symptoms of rosacea.